These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 761675)

  • 21. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-year rates for Nova T and Copper T in a comparative study.
    Allonen H; Luukkainen T; Nielsen NC; Nygren KG; Pyörälä T
    Contraception; 1980 Apr; 21(4):321-34. PubMed ID: 6993095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
    Sivin I; Stern J; Coutinho E; Mattos CE; el Mahgoub S; Diaz S; Pavez M; Alvarez F; Brache V; Thevenin F
    Contraception; 1991 Nov; 44(5):473-80. PubMed ID: 1797462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The intrauterine device today.
    Rioux JE
    J SOGC; 1993 Oct; 15(8):921-4. PubMed ID: 12318529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nova-T and Copper-T 200 in a five year's clinical comparison].
    Nygren KG; Allonen H; Nielsen NC; Luukkainen T; Pyorala T
    Contracept Fertil Sex (Paris); 1983 Nov; 11(11):1179-84. PubMed ID: 12312701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rise and fall and rise of the IUD.
    Burnhill MS
    Am J Gynecol Health; 1989; 3(3-S):6-10. PubMed ID: 12285000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Milestones in intrauterine device development.
    Tatum HJ
    Fertil Steril; 1983 Feb; 39(2):141-3. PubMed ID: 6401633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with today's IUDs.
    Pasquale S
    Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S25-9. PubMed ID: 8972499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with the uterine progesterone system (Progestasert R).
    Zador G; Nilsson BA; Nilsson B; Sjöberg NO; Weström L; Wiese J
    Contraception; 1976 May; 13(5):559-69. PubMed ID: 1261259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum cortisol level in lactating women using Progestasert system.
    Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four-year study.
    Wilson JC
    Am J Obstet Gynecol; 1989 Feb; 160(2):391-6. PubMed ID: 2916624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of the ease of removal of intrauterine contraceptive devices.
    Roke CM
    Contraception; 1988 Jun; 37(6):555-63. PubMed ID: 3396356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scanning and transmission electron microscopy of material adherent to intrauterine contraceptive devices.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):155-62. PubMed ID: 7362803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical study of a progesterone-releasing intrauterine contraceptive device.
    Brenner PF; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1975 Mar; 121(5):704-6. PubMed ID: 1115173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
    Videla-Rivero L; Etchepareborda JJ; Kesseru E
    Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medicated stainless steel ring-165, medicated gamma-intrauterine devices and TCu220C: a multicenter comparative study].
    Zhuang L; Yang B; Yuan H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Feb; 32(2):97-101. PubMed ID: 9596880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.